Sample Size Based on Pharmacodynamic endpoints [Power / Sample Size]

posted by sury – India, 2019-04-03 12:28  – Posting: # 20117
Views: 757

Hii All,

Hope all are doing well....

Recently i have received to provide the sample size based on the Pharmacodynamic endpoints.

As we use the ISCV for the estimation of sample size in general Bioequivalence studies.

Can anyone have any idea how can we provide sample size for the PD endpopints


Responses are highly appreciated.:-)

Thanks all


Edit: Category changed; see also this post #1[Helmut]

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,595 posts in 4,156 threads, 1,341 registered users;
online 7 (1 registered, 6 guests [including 5 identified bots]).
Forum time (Europe/Vienna): 01:27 CEST

I never did anything worth doing by accident,
nor did any of my inventions come by accident;
they came by work.    Thomas Alva Edison

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5